Business Description
Concord Biotech Ltd
ISIN : INE338H01029
Compare
Compare
Traded in other countries / regions
CONCORDBIO.India IPO Date
2023-08-18Description
Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 10.95 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.05 | |||||
| Interest Coverage | 99.38 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 49.21 | |||||
| Beneish M-Score | -2.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 18.6 | |||||
| 3-Year EBITDA Growth Rate | 17.3 | |||||
| 3-Year EPS without NRI Growth Rate | 14.1 | |||||
| 3-Year Book Growth Rate | 18.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 84.86 | |||||
| 9-Day RSI | 76.24 | |||||
| 14-Day RSI | 69.74 | |||||
| 6-1 Month Momentum % | 28.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.51 | |||||
| Quick Ratio | 3.2 | |||||
| Cash Ratio | 1.5 | |||||
| Days Inventory | 364.81 | |||||
| Days Sales Outstanding | 104.12 | |||||
| Days Payable | 143.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 0.2 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 77.19 | |||||
| Operating Margin % | 41.49 | |||||
| Net Margin % | 32.11 | |||||
| FCF Margin % | 16.52 | |||||
| ROE % | 23.02 | |||||
| ROA % | 19.86 | |||||
| ROIC % | 24.1 | |||||
| ROC (Joel Greenblatt) % | 36.68 | |||||
| ROCE % | 30.52 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 56.97 | |||||
| PE Ratio without NRI | 57.57 | |||||
| PS Ratio | 18.29 | |||||
| PB Ratio | 12.8 | |||||
| Price-to-Tangible-Book | 12.81 | |||||
| Price-to-Free-Cash-Flow | 110.73 | |||||
| Price-to-Operating-Cash-Flow | 65.64 | |||||
| EV-to-EBIT | 41.45 | |||||
| EV-to-EBITDA | 36.63 | |||||
| EV-to-Revenue | 18.05 | |||||
| EV-to-FCF | 109.26 | |||||
| Price-to-Graham-Number | 5.73 | |||||
| Price-to-Net-Current-Asset-Value | 31.02 | |||||
| Price-to-Net-Cash | 316.31 | |||||
| Earnings Yield (Greenblatt) % | 2.41 | |||||
| FCF Yield % | 0.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Concord Biotech Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 9,479.051 | ||
| EPS (TTM) (₹) | 29.091 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 69.74 | ||
| 14-Day ATR (₹) | 60.387259 | ||
| 20-Day SMA (₹) | 1550.7125 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (₹) | 900 - 1677 | ||
| Shares Outstanding (Mil) | 104.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Concord Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Concord Biotech Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Concord Biotech Ltd Frequently Asked Questions
What is Concord Biotech Ltd(BOM:543960)'s stock price today?
The current price of BOM:543960 is ₹1657.45. The 52 week high of BOM:543960 is ₹1677.00 and 52 week low is ₹900.00.
When is next earnings date of Concord Biotech Ltd(BOM:543960)?
The next earnings date of Concord Biotech Ltd(BOM:543960) is .
Does Concord Biotech Ltd(BOM:543960) pay dividends? If so, how much?
Concord Biotech Ltd(BOM:543960) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers